Three-dimensional distribution of the vitelliform lesion, photoreceptors, and retinal pigment epithelium in the macula of patients with best vitelliform macular dystrophy.

OBJECTIVE To describe the anatomical phenotypes of Best vitelliform macular dystrophy (BVMD) with spectral-domain optical coherence tomography (SD-OCT) in a large series of patients with confirmed mutations in the BEST1 gene. METHODS In our retrospective observational case series, we assessed 15 patients (30 eyes) with a clinical diagnosis of vitelliform macular dystrophy who were found to have mutations in the BEST1 gene. Color fundus photographs and SD-OCT images were evaluated and compared with those of 15 age-matched controls (30 eyes). Using a validated 3-dimensional SD-OCT segmentation algorithm, we calculated the equivalent thickness of photoreceptors and the equivalent thickness of the retinal pigment epithelium for each patient. The photoreceptor equivalent thickness and the retinal pigment epithelium (RPE) equivalent thickness were compared in all patients, in a region of the macula outside the central lesion for patients with BVMD and outside the fovea in control patients. Paired t tests were used for statistical analysis. RESULTS The SD-OCT findings revealed that the vitelliform lesion consists of material above the RPE and below the outer segment tips. Additionally, drusen-like deposition of sub-RPE material was notable, and several patients exhibited a sub-RPE fibrotic nodule. Patients with BVMD had a mean photoreceptor equivalent thickness of 28.3 μm, and control patients had a mean photoreceptor equivalent thickness of 21.8 μm, a mean difference of 6.5 μm (P < .01), whereas the mean RPE equivalent thickness was not statistically different between patients with BVMD and control patients (P = .53). CONCLUSIONS The SD-OCT findings suggest that vitelliform material is located in the subretinal space and that BVMD is associated with diffuse photoreceptor outer segment abnormalities overlying a structurally normal RPE. CLINICAL RELEVANCE These findings provide new insight into the pathophysiology of BVMD and thus have implications for the development of therapeutic interventions.

[1]  J. Kobrin,et al.  Histopathology of Best's macular dystrophy. , 1982, Archives of ophthalmology.

[2]  Yuan-yuan Cui,et al.  Looking chloride channels straight in the eye: bestrophins, lipofuscinosis, and retinal degeneration. , 2005, Physiology.

[3]  H. C. Hartzell,et al.  The Best Disease-Linked Cl− Channel hBest1 Regulates CaV1 (L-type) Ca2+ Channels via src-Homology-Binding Domains , 2008, The Journal of Neuroscience.

[4]  E. Souied,et al.  High-definition optical coherence tomography features in vitelliform macular dystrophy. , 2008, American journal of ophthalmology.

[5]  H. C. Hartzell,et al.  Regulation of Bestrophin Cl Channels by Calcium: Role of the C Terminus , 2008, The Journal of general physiology.

[6]  F. Best.  II. Über eine hereditäre Maculaaffektion , 1905 .

[7]  J. Nathans,et al.  Structure-Function Analysis of the Bestrophin Family of Anion Channels* , 2003, Journal of Biological Chemistry.

[8]  S. Tsang,et al.  Multimodal fundus imaging in Best vitelliform macular dystrophy , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.

[9]  S. Fine,et al.  A histopathologic study of Best's macular dystrophy. , 1982, Archives of ophthalmology.

[10]  B. Lorenz,et al.  Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration , 2000, European Journal of Human Genetics.

[11]  R. Steinberg,et al.  Effects of DIDS on the chick retinal pigment epithelium. II. Mechanism of the light peak and other responses originating at the basal membrane , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[12]  J. Kelsey,et al.  NEW CLINICAL TEST OF RETINAL FUNCTION BASED UPON THE STANDING POTENTIAL OF THE EYE* , 1962, The British journal of ophthalmology.

[13]  Xiaodong Wu,et al.  Automated segmentation of intraretinal layers from macular optical coherence tomography images , 2007, SPIE Medical Imaging.

[14]  M. Sonka,et al.  Association of visual function and ganglion cell layer thickness in patients with diabetes mellitus type 1 and no or minimal diabetic retinopathy , 2011, Vision Research.

[15]  J. Hollyfield,et al.  Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[16]  H. C. Hartzell,et al.  Suppression of Ca2+ signaling in a mouse model of Best disease. , 2010, Human molecular genetics.

[17]  H. Stöhr,et al.  Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (Best's disease). , 1998, Human molecular genetics.

[18]  S. Jacobson,et al.  Missense mutations in a retinal pigment epithelium protein, bestrophin-1, cause retinitis pigmentosa. , 2009, American journal of human genetics.

[19]  Xiaodong Wu,et al.  Automated 3-D Intraretinal Layer Segmentation of Macular Spectral-Domain Optical Coherence Tomography Images , 2009, IEEE Transactions on Medical Imaging.

[20]  H. C. Hartzell,et al.  Molecular physiology of bestrophins: multifunctional membrane proteins linked to best disease and other retinopathies. , 2008, Physiological reviews.

[21]  C. Wadelius,et al.  The mutation spectrum of the bestrophin protein – functional implications , 1999, Human Genetics.

[22]  A. M. Potts,et al.  Hereditary vitelliruptive macular degeneration. , 1966, American journal of ophthalmology.

[23]  M. Metzker,et al.  Identification of the gene responsible for Best macular dystrophy , 1998, Nature Genetics.

[24]  D. Mackey,et al.  AUTOSOMAL RECESSIVE VITELLIFORM MACULAR DYSTROPHY IN A LARGE COHORT OF VITELLIFORM MACULAR DYSTROPHY PATIENTS , 2011, Retina.

[25]  D. M. Gass,et al.  A clinicopathologic study of a peculiar foveomacular dystrophy. , 1974, Transactions of the American Ophthalmological Society.

[26]  G. Fishman,et al.  Visual acuity in patients with best vitelliform macular dystrophy. , 1993, Ophthalmology.

[27]  V. Sheffield,et al.  Allelic variation in the VMD2 gene in best disease and age-related macular degeneration. , 2000, Investigative ophthalmology & visual science.

[28]  A. Marmorstein,et al.  Focus on molecules: bestrophin (best-1). , 2007, Experimental eye research.

[29]  E. Stone,et al.  Late development of vitelliform lesions and flecks in a patient with best disease: clinicopathologic correlation. , 2005, Archives of ophthalmology.

[30]  H. Stöhr,et al.  High-resolution meiotic and physical mapping of the best vitelliform macular dystrophy (VMD2) locus to pericentromeric chromosome 11. , 1994, American journal of human genetics.

[31]  J. Hollyfield,et al.  Regional variation within the interphotoreceptor matrix from fovea to the retinal periphery , 1990, Eye.

[32]  C. Wadelius,et al.  Enhanced accumulation of A2E in individuals homozygous or heterozygous for mutations in BEST1 (VMD2). , 2007, Experimental eye research.

[33]  V. Sheffield,et al.  Genetic linkage of vitelliform macular degeneration (Best's disease) to chromosome 11q13 , 1992, Nature Genetics.

[34]  G. Holder,et al.  Biallelic mutation of BEST1 causes a distinct retinopathy in humans. , 2008, American journal of human genetics.

[35]  E. Stone,et al.  Phenotypic variability due to a novel Glu292Lys variation in exon 8 of the BEST1 gene causing best macular dystrophy. , 2009, Archives of ophthalmology.

[36]  N. Peachey,et al.  The Light Peak of the Electroretinogram Is Dependent on Voltage-gated Calcium Channels and Antagonized by Bestrophin (Best-1) , 2006, The Journal of general physiology.

[37]  D. Anderson,et al.  The relationship of primate foveal cones to the pigment epithelium. , 1979, Journal of ultrastructure research.

[38]  J. Nathans,et al.  The vitelliform macular dystrophy protein defines a new family of chloride channels , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[39]  C. Wadelius,et al.  Expression of bestrophin‐1, the product of the VMD2 gene, modulates voltage‐dependent Ca2+ channels in retinal pigment epithelial cells , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  R. L. Font,et al.  Foveomacular vitelliform dystrophy, adult type. A clinicopathologic study including electron microscopic observations. , 1985, Ophthalmology.

[41]  E. Stone,et al.  Differential macular and peripheral expression of bestrophin in human eyes and its implication for best disease. , 2007, Investigative ophthalmology & visual science.

[42]  G. Fishman,et al.  Histopathologic findings in Best's vitelliform macular dystrophy. , 1988, Archives of ophthalmology.

[43]  G. Fishman,et al.  Autosomal dominant vitreoretinochoroidopathy. , 1982, Archives of ophthalmology.